MR. MICHAEL JOSEPH MARICIC MD NPI 1720179971

NPI Details

MR. Michael Joseph Maricic, MD is a rheumatology internal medicine in Tucson, AZ with 48 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. MR. Michael Joseph Maricic, MD NPI is 1720179971. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

7520 N ORACLE RD SUITE 100
CATALINA POINTE ARTHRITIS & RHEUMATOLOGY SPECIALIST, PC
TUCSON, AZ
ZIP 85704
Phone: (520) 408-1133
Fax: (520) 408-2233

The NPI 1720179971 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Aspiration and/or injection of fluid from medium joint (HCPCS:20605)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk (HCPCS:77089)

The enumeration date for this NPI number is 9/27/2006 and was last updated on 4/7/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.